Adagene Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of antibody-based immunotherapies for the treatment of cancer and other diseases. Their innovative approach to drug discovery and their strong pipeline of candidates make them an exciting player in the field of oncology.
